IIM
ABEO icon

INTECH Investment Management’s Abeona Therapeutics ABEO Stock Holding History

INTECH Investment Management’s Portfolio ABEO Stock Details ABEO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$54.6K Sell
12,193
-9,056
-43% -$45.3K ﹤0.01% 1997
2025
Q4 		$112K Sell
21,249
-3,927
-16% -$19.8K ﹤0.01% 2136
2025
Q3 		$133K Buy
25,176
+4,127
+20% +$26.2K ﹤0.01% 2183
2025
Q2 		$120K Buy
+21,049
New +$120K ﹤0.01% 2250

Other funds holding ABEO

NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
ACM
AIGH Capital Management Baltimore, Maryland $733M AUM 327.32% 1-Year Est. Return
CCC
Cable Car Capital San Francisco, California $289M AUM 26.33% 1-Year Est. Return
SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
PBM
Propel Bio Management Los Angeles, California $159M AUM 60.94% 1-Year Est. Return
KCM
Kennedy Capital Management St Louis, Missouri $4.72B AUM 36.69% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

INTECH Investment Management's ABEO Position: Q1 2026 in Review

INTECH Investment Management reduced its Abeona Therapeutics (ABEO) stake by 43% in Q1 2026, selling an estimated $45.3K and leaving 12,193 shares worth $54.6K. The position accounts for ﹤0.01% of the portfolio, ranked #1997.

INTECH Investment Management first reported a position in ABEO in Q2 2025 and has held it in 4 quarters since. The position peaked at $133K in Q3 2025. 108 funds tracked by Wall St. Rank hold ABEO as of Q1 2026.

  • INTECH Investment Management held 12,193 shares of Abeona Therapeutics worth $54.6K as of Q1 2026.
  • INTECH Investment Management sold 9,056 Abeona Therapeutics shares in Q1 2026, an estimated $45.3K.
  • Abeona Therapeutics made up ﹤0.01% of INTECH Investment Management's portfolio in Q1 2026, its #1997 holding.
  • INTECH Investment Management first reported a position in Abeona Therapeutics in Q2 2025 and has held it in 4 quarters since.
  • INTECH Investment Management's Abeona Therapeutics position peaked at $133K in Q3 2025.
  • 108 funds tracked by Wall St. Rank held Abeona Therapeutics as of Q1 2026.

Based on INTECH Investment Management's 13F filing for Q1 2026, filed 8 May 2026.